Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T14:14:25.275Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Chlorhexidine Bathing on Hospital-Acquired Infections among General Medical Patients

Published online by Cambridge University Press:  02 January 2015

Steven Z. Kassakian ,
Leonard A. Mermel ,
Julie A. Jefferson ,
Stephen L. Parenteau  and
Jason T. Machan
Steven Z. Kassakian
Affiliation:
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
Leonard A. Mermel*
Affiliation:
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island Department of Epidemiology and Infection Control, Rhode Island Hospital, Providence, Rhode Island
Julie A. Jefferson
Affiliation:
Department of Epidemiology and Infection Control, Rhode Island Hospital, Providence, Rhode Island Department of Community Health, Warren Alpert Medical School of Brown University, Providence, Rhode Island
Stephen L. Parenteau
Affiliation:
Department of Epidemiology and Infection Control, Rhode Island Hospital, Providence, Rhode Island
Jason T. Machan
Affiliation:
Department of Orthopaedics and Department of Surgery, Warren Alpert Medical School of Brown University, Providence, Rhode Island
*
Division of Infectious Diseases, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

A paucity of data exists regarding the effectiveness of daily Chlorhexidine gluconate (CHG) bathing in non–intensive care unit (ICU) settings.

Objective.

To evaluate the effectiveness of daily CHG bathing in a non-ICU setting to reduce methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enteroccocus (VRE) hospital-acquired infections (HAIs), compared with daily bathing with soap and water.

Design.

Quasi-experimental study design; the primary outcome was the composite incidence of MRSA and VRE HAIs. Clostridium difficile HAI incidence was measured as a nonequivalent dependent variable with which to assess potential confounders.

Setting.

Four general medicine units, with a total of 94 beds, at a 719-bed academic tertiary-care facility in Providence, Rhode Island.

Patients.

A total of 7,102 and 7,699 adult patients were admitted to the medical service in the control and intervention groups, respectively. Patients admitted from January 1 through December 31, 2008, were bathed daily with soap and water (control group), and those admitted from February 1, 2009, through March 31, 2010, were bathed daily with CHG-impregnated cloths (intervention group).

Results.

Daily bathing with CHG was associated with a 64% reduced risk of developing the primary outcome, namely, the composite incidence of MRSA and VRE HAIs (hazard ratio, 0.36 [95% CI, 0.2-0.8]; P = .01). There was no change in the incidence of C. difficile HAIs (P = .6). Colonization with MRSA was associated with an increased risk of developing a MRSA HAI (hazard ratio, 8 [95% CI, 3-19]; P < .001).

Conclusion.

Daily CHG bathing was associated with a reduced HAI risk, using a composite endpoint of MRSA and VRE HAIs, in a general medical inpatient population.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 3 , March 2011 , pp. 238 - 243
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Vernon, MO, Hayden, MK, Trick, WE, Hayes, RA, Blom, DW, Weinstein, RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166(3):306–312.CrossRefGoogle Scholar
2.Bleasdale, SC, Trick, WE, Gonzalez, IM, Lyles, RD, Hayden, MK, Weinstein, RA. Effectiveness of Chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167(19):2073–2079.CrossRefGoogle ScholarPubMed
3.Popovich, KJ, Hota, B, Hayes, R, Weinstein, RA, Hayden, MK. Effectiveness of routine patient cleansing with Chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30(10):959–963.CrossRefGoogle ScholarPubMed
4.Climo, MW, Sepkowitz, KA, Zuccotti, G, et al.The effect of daily bathing with Chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococ-cus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37(6):1858–1865.CrossRefGoogle Scholar
5.Evans, HL, Dellit, TH, Chan, J, Nathens, AB, Maier, RV, Cuschieri, J. Effect of Chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010;145(3):240–246.CrossRefGoogle ScholarPubMed
6.Johnson, D, Lineweaver, L, Maze, LM. Patients' bath basins as potential sources of infection: a multicenter sampling study. Am J Crit Care 2009;18(1):31–38.CrossRefGoogle ScholarPubMed
7.Munoz-Price, LS, Hota, B, Sterner, A, Weinstein, RA. Prevention of bloodstream infections by use of daily Chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30(11):1031–1035.CrossRefGoogle Scholar
8.Arnold, MS, Dempsey, JM, Fishman, M, McAuley, PJ, Tibert, C, Vallande, NC. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002;23(2):69–76.CrossRefGoogle ScholarPubMed
9.Cohen, JB, Lane, T. Chlorhexidine bath admission protocol for prevention of healthcare-associated methicillin-resistant Staphylococcus aureus infection: results of a hospital wide initiative. In: Program and abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections, March 18-22, 2010, 2010; Atlanta, GA. Abstract 519.Google Scholar
10.Safdar, N, Bradley, EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008;121(4):310–315.CrossRefGoogle ScholarPubMed
11.Harris, AD, Bradham, DD, Baumgarten, M, Zuckerman, IH, Fink, JC, Perencevich, EN. The use and interpretation of quasiexperimental studies in infectious diseases. Clin Infect Dis 2004;38(11):1586–1591.Google ScholarPubMed
12.Milstone, AM, Passaretti, CL, Perl, TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008;46(2):274–281.Google ScholarPubMed
13.Wang, JT, Sheng, WH, Wang, JL, et al.Longitudinal analysis of Chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Antimicrob Chemother 2008;62(3):514–517.CrossRefGoogle Scholar
14.Batra, R, Cooper, BS, Whiteley, C, Patel, AK, Wyncoll, D, Edgeworth, JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50(2):210–217.CrossRefGoogle Scholar